NUC01 clinical trials

Double-blind, randomized, placebo-controlled, phase III study comparing norursodeoxycholic acid capsules with placebo in the treatment of primary sclerosing cholangitis

This study is looking into a new medication called NUC01 for a liver condition called primary sclerosing cholangitis (PSC). It compares NUC01 with a dummy medicine (placebo) to see if it can improve liver health and stop the condition from getting worse.